Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects
Clinical trial NCT04965337 · COMPLETED
Trial details
- NCT number
- NCT04965337
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-11
- Primary completion
- 2021-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.